Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery.
This paper describes the management of three patients for elective surgery with drug-eluting stents in the coronary circulation. The risks posed at the time of surgery by such patients include acute coronary syndromes, as a result of stent thrombosis, after cessation of anti-platelet therapy and excessive bleeding from continued anti-platelet therapy. We describe a regime for the management of such patients that successfully avoided these risks in three patients with paclitaxel drug-eluting stents requiring elective non-cardiac surgery.
Broad
L
L
Department of Perioperative Medicine, Anaesthesia & Pain Management, The Geelong Hospital, Barwon Health Ryrie Street, Geelong, Victoria 3220, Australia.
Lee
T
T
Conroy
M
M
Bolsin
S
S
Orford
N
N
Black
A
A
Birdsey
G
G
D000368:Aged; D000077144:Clopidogrel; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000517:prevention & control*; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems; D017558:Elective Surgical Procedures; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D019990:Perioperative Care / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D015607:Stents; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives
D020099:Coated Materials, Biocompatible; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D017239:Paclitaxel